Insitro, Inc. — Form D
Insitro, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2020-05-27. The offering totals $143.2M, of which $143.2M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-05-27
- Form: D
- Accession: 0001567619-20-011207
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $143.2M
- Amount sold: $143.2M
- Investors: 26
- Date of first sale: 2020-03-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-367759
Issuer
- Name: Insitro, Inc.
- CIK: 0001812648
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2018
- Address: 279 East Grand Avenue, Suite 200, South San Francisco, CA, 94080
- Phone: (650) 730-7074
Officers, directors & promoters (6)
| Name | Role | Location |
|---|
| Daphne Koller | Director | San Mateo, CA |
| Robert Nelsen | Director | Seattle, WA |
| Vijay Pande | Director | Richmond, CA |
| Daphne Koller | Executive Officer | San Mateo, CA |
| Mary Rozenman | Executive Officer | South San Francisco, CA |
| Duane Valz | Executive Officer | South San Francisco, CA |
More